Finzati - Logo
FTRE logo

Fortrea Holdings Inc.

FTRE • Biotechnology
$17.70
▼ -0.92 (-4.94%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.67B
Growth
0.5%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 0.97Consistent free cash flow · 5/5Manageable debt level · 0.12Weak liquidity · 0.98Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$17.70
Change-4.94%
Shares Out94.29M
Market Cap$1.67B
Enterprise Value$1.58B
52W Range5.26 - 21.39
Beta2.01
P/E-19.59
P/S0.62
P/B3.18
P/FCF11.08
EV/Sales0.59

Investment DNA

How strong this company looks for long-term investors

51
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
55/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score▼
Positive free cash flow · 0.97Consistent free cash flow · 5/5Manageable debt level · 0.12Weak liquidity · 0.98Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

FTRE
Analyst sentiment
Based on 12 analyst votes · 2026-09-05
67/100
Neutral
Bullish
5
Hold
6
Bearish
1
Price Target
2026-07-31
Low
$16.00
Mean
$20.00
Median
$20.00
High
$23.00

Company Overview

IPO: 6/20/2023
Industry: Biotechnology
P/B i: 3.18
Debt / Equity i: 0.12
Operating Margin: -1.12%
Net Margin: -36.21%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: 0.12
Current Ratio: 0.98
Quick Ratio: 0.98
Status: Moderate

Warnings

  • Weak Liquidity

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Smith David Ross
Transaction: 07/20/2026
BUY
Change
+6,598
Price
Not reported
Filing
07/27/2026
Type
BUY
Knoblauch Jason Fredrick
Transaction: 07/06/2026
OTHER
Change
0
Price
Not reported
Filing
07/15/2026
Type
OTHER
Russell Erin L
Transaction: 06/10/2026
SELL
Change
-38,817
Price
Not reported
Filing
06/12/2026
Type
SELL